CDK1 and pancreatic neoplasm: KEGG and GO enrichment analysis revealed that cell cycle signaling pathway was significantly different in gemcitabine-resistant human pancreatic cancer PANC-1 cells, among which CDK1 was highly expressed in drug-resistant cells (Fig. 1c–e).